A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: Distribution and efficacy in experimental human ovarian cancer

P. H J Houba, E. Boven, I. H. Van Der Meulen-Muileman, R. G G Leenders, J. W. Scheeren, H. M. Pinedo, H. J. Haisma

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: Distribution and efficacy in experimental human ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences